Dexamethasone protects against membrane formation

Article

Dexamethasone protects against anterior membrane formation and doesn’t increase glaucoma risk.

Dexamethasone protects against anterior membrane formation and doesn’t increase glaucoma risk.

The retrospective case series, led by Dr Asimina Mataftsi, Clinical and Academic Department of Ophthalmology, London, UK, was comprised of 24 eyes of 18 infants who underwent cataract surgery with IOLs between January 1, 2007 and December 31, 2008.

Mean follow-up was 38 months and the median age at surgery was three months. Transient postoperative antihypertensive medication was used in four eyes, but there was no development of glaucoma during the follow-up period.

Of the eyes studied, 15 underwent a second procedure to clear the visual axis caused by posterior visual axis opacification. No eyes developed anterior membranes and Intracameral preservative-free dexamethasone doesn't seem to cause increased glaucoma risk.

To read the abstract please visit the Journal of Cataract and Refractive Surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.